Q&A with Dr. Dean Kereiakes about the Disrupt CAD III 1yr Data at TCT21
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Q&A with Dr. Dean Kereiakes about the Disrupt CAD III 1yr Data at TCT21
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2
Calcium causes a magnitude of problems in EVAR and TEVAR procedures. Calcium can inhibit stent graft delivery leading to significant dissection or perforation of the iliac arteries. Calcium can also affect expansion of iliac limbs leading to increased risk of under expansion and stent graft thrombosis.
Watch as Dr. Stefano Fazzini, Tor Vergata University Hospital, Italy walks you through how Shockwave IVL can help alleviate access challenges while minimizing complications and the need for secondary interventions.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
Dr. Andrew Klein, Staff Interventional Cardiologist at Piedmont Heart and Vascular Institute in Atlanta shares his valuable experience with coronary IVL. Dr. Klein speaks about his approach to different types of calcific lesions including use of coronary IVL, sharing his best tips and tricks with the technology when used as a stand alone therapy and in combination with other calcium modification tools.
Topics: Coronary IVL, Shockwave C2, Calcium Corner
We’ve all heard that Shockwave IVL doesn’t work in eccentric calcium… well that’s just a myth. Watch Prof. Andrew Holden’s presentation from CIRSE21 as he walks you through IVL’s eccentric vs concentric lesion data subset from the PADIII Observational Study and learn how this myth can well and truly be dispelled.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data, Treating Different Ca++ Morphologies
In anticipation of TCT starting in early November, we had quick conversation with Shockwave Medical’s Chief Medical Officer, Dr. Keith Dawkins, about IVL’s presence at the meeting and the most interesting data coming out. Hope you enjoy his perspective!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
Explore the new world of Shockwave with Paul Higginbottom, Director of Sales in the UK and France, in ChalkTalk episode five. With over 10+ years in the medical device industry and a complex PCI background, Paul recounts the joys of his career journey but explains how the unique attributes of IVL and start-up environment are what compelled him to join Shockwave at the beginning of this year. He provides insights into Shockwave’s culture, shares challenges that he has faced already, and talks about going direct in the UK and France. Listen to catch Paul’s first interactions with physicians and their surprising feedback – enjoy!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
This year at TCT 2021, we’re pulling out all the stops. With inpatient and outpatient reimbursement now in place, we’ve delved deeper into the current coronary IVL clinical evidence to get data-driven answers for some of your most pressing questions:
Topics: Coronary IVL
Dr. Ehrin Armstrong presented the interim results from the first 752 patients in the Disrupt PAD III Observational Study (OS), reinforcing the consistency of IVL's unique mechanism of action to safely and effectively modify superficial and deep calcium across multiple vessel beds, lesion types and CLI patients.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
Eccentric calcium has challenged current modalities’ ability to adequately modify calcium due to several device-dependent factors. NC balloons often expand the healthy, non-calcified side of the artery, while high pressure or cutting balloons may result in disruption or dissection of healthy intima. Even atherectomy devices are limited due to wire bias that may often result in nonuniform ablation of calcium leaving the calcified plaque untouched.
Topics: Coronary IVL, Shockwave C2, Treating Different Ca++ Morphologies
Dr. Evan Shlofmitz, DO, Director of Intravascular Imaging, St. Francis Hospital - The Heart Center, Roslyn, New York shares with us his extensive experience with imaging modalities and how the use of intravascular imaging helped create treatment algorithms at St. Francis Hospital to decide on the appropriate calcium modification tool. He also speaks about his experience with Coronary IVL, its safety and the use of OCT to enhance our ability to use intravascular lithotripsy, including case selection and ensuring adequate outcomes.
Topics: Coronary IVL, Shockwave C2, Calcium Corner
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
